Clinical Trials Browser

Phase 2 × Ovarian Neoplasms × Bortezomib × Clear all

NCT00610792 2009-07-14

Phase 2 Study of Twice Weekly VELCADE and CAELYX in Patients With Ovarian Cancer Failing Platinum Containing Regimens

Phase 2 Withdrawn

Ovarian Neoplasms